Recombinant Rat TLR4/CD284 Protein，His & SUMO

Toll-like receptor 4 (TLR4), also known as CD284, is a crucial component of the innate immune system, playing a pivotal role in recognizing pathogens and initiating immune responses. TLR4 is primarily known for its ability to detect lipopolysaccharides (LPS) from gram-negative bacteria, thereby triggering a cascade of inflammatory responses through the activation of downstream signaling pathways, including the MyD88-dependent and TRIF-dependent pathways. The importance of TLR4 in mediating immune responses makes it a significant target for research in immunology, vaccine development, and therapeutic interventions for various diseases, including sepsis, autoimmune disorders, and cancer. Recombinant TLR4/CD284 proteins are essential for studying the receptor's structure, function, and interactions with other molecules and for assessing the therapeutic potential of TLR4 modulation. By generating recombinant TLR4, researchers can analyze its role in immune signaling, investigate the effects of LPS and other agonists, and explore how TLR4 may be manipulated to enhance vaccine efficacy or attenuate harmful inflammatory responses. Furthermore, understanding TLR4/CD284 signaling pathways may provide insights into designing novel immunotherapeutics and adjuvants, making it a central topic in both fundamental and applied immunological research. The ongoing exploration of TLR4 reveals its significant implications for health and disease, highlighting the need for advanced studies utilizing recombinant proteins to elucidate its complex biology and therapeutic potential.